BMS-184476

Star0

DB12633InvestigationalSmall molecule

BMS-184476 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Formula / weight: C₄₉H₅₅NO₁₄S · 914.03 g/mol (avg)
Code names: BMS-184476

Resolves to

Compound

UNII3811W2NBZ8CAS160237-25-2PubChem6918461

Structure

InChIKeyUBJAHGAUPNGZFF-XOVTVWCYSA-NSMILES

CSCO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]12C)C3(C)C

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of BMS-184476, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account